EMCDDA–Europol Joint Report on a new psychoactive substance: N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide (ADB-CHMINACA) 21. September 2017, section EMCDDA news
16. February 2024 Technical dialogue on cannabis policies kicks off in Montevideo This week in Montevideo, the EMCDDA is co-organising with the Uruguayan Junta Nacional de Drogas, a technical dialogue on...
